Dolphin Medical Services Ltd.
| BSE: 526504 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE796B01013 |
| BSE 00:00 | 20 Jun | 1.67 |
0 (0.00%) |
OPEN
1.75 |
HIGH
1.75 |
LOW
1.67 |
| NSE 05:30 | 01 Jan | Dolphin Medical Services Ltd |
| OPEN | 1.75 |
| PREVIOUS CLOSE | 1.67 |
| VOLUME | 28385 |
| 52-Week high | 5.01 |
| 52-Week low | 1.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dolphin Medical Services Ltd. (DOLPHINMEDICAL) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 526.40 | 9.05 | 1.75 | 3112.91 |
| Cipla | 933.40 | 0.40 | 0.04 | 2468.28 |
| Dr Reddy's Labs | 4308.75 | 12.55 | 0.29 | 2186.40 |
| Sun Pharma.Inds. | 824.10 | -0.60 | -0.07 | 2139.70 |
| Divi's Lab. | 3680.40 | 13.80 | 0.38 | 1954.72 |
| Alkem Lab | 3003.85 | -34.80 | -1.15 | 1685.08 |
| Glenmark Pharma. | 383.75 | 6.90 | 1.83 | 1649.45 |
| Zydus Lifesci. | 353.70 | 7.55 | 2.18 | 1476.20 |
| Lupin | 629.95 | 0.95 | 0.15 | 1258.62 |
| Alembic Pharma | 726.10 | 1.65 | 0.23 | 1175.39 |
| Ipca Labs. | 888.95 | -6.80 | -0.76 | 1140.77 |
| Torrent Pharma. | 2875.50 | 21.00 | 0.74 | 1137.85 |
| Gland Pharma | 2643.70 | 36.60 | 1.40 | 997.01 |
| Sanofi India | 6410.00 | -80.10 | -1.23 | 944.40 |
| Laurus Labs | 466.60 | 7.00 | 1.52 | 750.09 |
| Abbott India | 18088.00 | 61.50 | 0.34 | 690.69 |
| Ajanta Pharma | 1249.85 | 36.00 | 2.97 | 675.64 |
| Wockhardt | 221.25 | -0.65 | -0.29 | 593.29 |
| Granules India | 256.65 | 12.20 | 4.99 | 552.78 |
| Pfizer | 4102.30 | -10.30 | -0.25 | 497.61 |
Quick Links for Dolphin Medical Services:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
